Welcome to LookChem.com Sign In|Join Free
  • or
4-[(methylamino)methyl]phenol, a derivative of phenol with the molecular formula C9H13NO, is a chemical compound that features a methylamino group attached to the phenol ring. It is known for its versatile applications in various industries, although its toxicity necessitates careful handling to prevent potential health hazards.

78507-19-4

Post Buying Request

78507-19-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

78507-19-4 Usage

Uses

Used in Pharmaceutical Industry:
4-[(methylamino)methyl]phenol serves as a key chemical intermediate in the synthesis of various pharmaceuticals. Its unique structure allows it to be incorporated into the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Dye Industry:
In the dye industry, 4-[(methylamino)methyl]phenol is utilized in the production of different types of dyes. Its chemical properties enable it to impart color to various materials, making it a valuable component in creating a wide range of colorants.
Used in Chemical Synthesis:
4-[(methylamino)methyl]phenol plays a crucial role in organic synthesis, where it acts as a building block for the creation of more complex organic compounds. Its reactivity and functional groups make it a versatile component in the synthesis of various organic molecules.
Used as a Reagent in Chemical Reactions:
Due to its reactive nature, 4-[(methylamino)methyl]phenol is employed as a reagent in various chemical reactions. It facilitates specific transformations and serves as a catalyst in certain processes, further expanding its utility in the chemical domain.

Check Digit Verification of cas no

The CAS Registry Mumber 78507-19-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,5,0 and 7 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 78507-19:
(7*7)+(6*8)+(5*5)+(4*0)+(3*7)+(2*1)+(1*9)=154
154 % 10 = 4
So 78507-19-4 is a valid CAS Registry Number.

78507-19-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[(Methylamino)methyl]phenol

1.2 Other means of identification

Product number -
Other names N-methyl-4-phenylbenzylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:78507-19-4 SDS

78507-19-4Relevant academic research and scientific papers

Phenyl ether- and aniline-containing 2-aminoquinolines as potent and selective inhibitors of neuronal nitric oxide synthase

Cinelli, Maris A.,Li, Huiying,Pensa, Anthony V.,Kang, Soosung,Roman, Linda J.,Martásek, Pavel,Poulos, Thomas L.,Silverman, Richard B.

supporting information, p. 8694 - 8712 (2015/11/25)

Excess nitric oxide (NO) produced by neuronal nitric oxide synthase (nNOS) is implicated in neurodegenerative disorders. As a result, inhibition of nNOS and reduction of NO levels is desirable therapeutically, but many nNOS inhibitors are poorly bioavailable. Promising members of our previously reported 2-aminoquinoline class of nNOS inhibitors, although orally bioavailable and brain-penetrant, suffer from unfavorable off-target binding to other CNS receptors, and they resemble known promiscuous binders. Rearranged phenyl ether- and aniline-linked 2-aminoquinoline derivatives were therefore designed to (a) disrupt the promiscuous binding pharmacophore and diminish off-target interactions and (b) preserve potency, isoform selectivity, and cell permeability. A series of these compounds was synthesized and tested against purified nNOS, endothelial NOS (eNOS), and inducible NOS (iNOS) enzymes. One compound, 20, displayed high potency, selectivity, and good human nNOS inhibition, and retained some permeability in a Caco-2 assay. Most promisingly, CNS receptor counterscreening revealed that this rearranged scaffold significantly reduces off-target binding.

N-Nitrosobenzylmethylamine hydroxylation and coumarin 7-hydroxylation: Catalysis by rat esophageal microsomes and cytochrome P450 2A3 and 2A6 enzymes

Von Weymarn, Linda B.,Felicia, Nadia D.,Ding, Xinxin,Murphy, Sharon E.

, p. 1254 - 1261 (2007/10/03)

N-Nitrosobenzylmethylamine (NBzMA) is a potent and selective esophageal carcinogen in the rat and may be a causative agent for human esophageal cancer. This nitrosamine, like most, must be metabolically activated to exert its carcinogenic potential. NBzMA may be metabolized by P450-catalyzed methyl or methylene hydroxylation; the latter is believed to be the activation pathway. The sensitivity of the esophagus to NBzMA-induced tumorigenesis is believed to be due, at least in part, to the presence of efficient P450 catalysts in this tissue. However, while it was reported almost 20 years ago that the rat esophagus catalyzes the methylene hydroxylation of NBzMA, the P450 that catalyzes this reaction has yet to be identified. We report here that human P450 2A6 and the closely related extrahepatic rat enzyme P450 2A3 both efficiently catalyze NBzMA methylene hydroxylation, characterized as benzaldehyde formation. The catalytic efficiency of P450 2A3 in this reaction was 3-fold greater than that of P450 2A6, 7.6 (K(m) = 0.63 ± 0.18 μM and the V(max) = 4.8 nmol min-1 nmol of P450-1) versus 2.3 (K(m) = 6.7 ± 2.9 μM and the V(max) = 15.7 nmol min-1 nmol of P450-1), respectively. Both enzymes catalyzed methylene hydroxylation at least 4-fold more efficiently than methyl hydroxylation. In addition, P450 2A6, but not P450 2A3, catalyzed benzyl ring hydroxylation, generating N-(p-hydroxybenzyl)methylamine. The identity of this metabolite was confirmed by synthesis of a standard and LC/MS and LC/MS/MS analysis. P450 2A6 is an efficient coumarin 7-hydroxylase, and we report here that P450 2A3 is an equally good catalyst of this reaction (K(m) = 1.7 ± 0.41 μM and V(max) = 1.7 ± 0.08 nmol min-1 nmol of P450- 1). Rat esophageal microsomes (REM), like P450 2A3, were efficient catalysts of NBzMA methylene hydroxylation. However, in contrast to P450 2A3, the major product of this reaction was the product of benzaldehyde oxidation, benzoic acid. Antibody to the closely related mouse P450, 2A5, did not inhibit REM- catalyzed NBzMA metabolism, and most importantly, REM did not catalyze the 7- hydroxylation of coumarin. Therefore, P450 2A3 does not appear to be the P450 in the rat esophagus responsible for catalyzing the methylene hydroxylation of NBzMA.

REACTIONS RETRODIENIQUES-XI SYNTHESE DE COMPOSES POLYINSATURES REACTIFS PAR DOUBLE REACTION DE RETRO-DIELS-ALDER

Lasne, M. C.,Ripoll, J. L.,Denis, J. M.

, p. 503 - 508 (2007/10/02)

Double retro-Diels-Alder cleavage by flash thermolysis gave the new, unstable polyunsaturated ketones and hydrocarbons 1-5 for which NMR, IR and UV spectra at low temperature are reported.The Diels-Alder adducts of compounds 1-3 with various dienes, the 1,6-additions of several nucleophilic agents with 4, and the isomerisation of 5 in p-ethynylstyrene support the proposed structures.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 78507-19-4